516 related articles for article (PubMed ID: 21658083)
1. Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.
Willems RJ; Hanage WP; Bessen DE; Feil EJ
FEMS Microbiol Rev; 2011 Sep; 35(5):872-900. PubMed ID: 21658083
[TBL] [Abstract][Full Text] [Related]
2. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens.
Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G
Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015.
Xu Z; Xie J; Peters BM; Li B; Li L; Yu G; Shirtliff ME
Microb Pathog; 2017 Feb; 103():80-86. PubMed ID: 27894963
[TBL] [Abstract][Full Text] [Related]
4. Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance.
Roberts AP; Mullany P
FEMS Microbiol Rev; 2011 Sep; 35(5):856-71. PubMed ID: 21658082
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic resistance of Gram-positive cocci isolated in 2008].
Dorobăţ OM; Bădicuţ I; Tălăpan D; Tenea C; Rafila A
Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):83-92. PubMed ID: 21553473
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
Severina E; Severin A; Tomasz A
J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.
Jones RN; Low DE; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):101-12. PubMed ID: 10091033
[TBL] [Abstract][Full Text] [Related]
8. Spread of multidrug-resistant Enterococcus to animals and humans: an underestimated role for the pig farm environment.
Novais C; Freitas AR; Silveira E; Antunes P; Silva R; Coque TM; Peixe L
J Antimicrob Chemother; 2013 Dec; 68(12):2746-54. PubMed ID: 23861310
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
10. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Gram-positive bacterial infection in patients following liver transplantation.
Li H; Yu DL; Ren L; Zhong L; Peng ZH; Teng MJ
Chin Med J (Engl); 2012 Jul; 125(14):2417-21. PubMed ID: 22882913
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Casellas JM
Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
[TBL] [Abstract][Full Text] [Related]
15. Emergence of high-risk multidrug-resistant Enterococcus faecalis CC2 (ST181) and CC87 (ST28) causing healthcare-associated infections in India.
Rao C; Dhawan B; Vishnubhatla S; Kapil A; Das B; Sood S
Infect Genet Evol; 2020 Nov; 85():104519. PubMed ID: 32877660
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of the aminoglycoside phosphotransferase genes aph(3')-IIIa and aph(3')-IIa in Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Pseudomonas aeruginosa, Salmonella enterica subsp. enterica and Staphylococcus aureus isolates in Austria.
Woegerbauer M; Zeinzinger J; Springer B; Hufnagl P; Indra A; Korschineck I; Hofrichter J; Kopacka I; Fuchs R; Steinwider J; Fuchs K; Nielsen KM; Allerberger F
J Med Microbiol; 2014 Feb; 63(Pt 2):210-217. PubMed ID: 24194558
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant enterococci in animal meat and faeces and co-transfer of resistance from an Enterococcus durans to a human Enterococcus faecium.
Vignaroli C; Zandri G; Aquilanti L; Pasquaroli S; Biavasco F
Curr Microbiol; 2011 May; 62(5):1438-47. PubMed ID: 21286720
[TBL] [Abstract][Full Text] [Related]
18. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN
J Antimicrob Chemother; 2015 Feb; 70(2):498-504. PubMed ID: 25362568
[TBL] [Abstract][Full Text] [Related]
19. Clonal spread of CC17 vancomycin-resistant Enterococcus faecium with multilocus sequence type 78 (ST78) and a novel ST444 in Taiwan.
Hsieh YC; Lee WS; Ou TY; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):25-30. PubMed ID: 19756785
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.
Grüneberg RN; Hryniewicz W
Int J Antimicrob Agents; 1998 Nov; 10(4):271-7. PubMed ID: 9916900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
